PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers

Abstract Objective Self‐limited infantile epilepsy (SeLIE) has distinctive clinical features, and the PRRT2 gene is known to be a considerable genetic cause. There have been a few studies on PRRT2‐positive SeLIE only, and anti‐seizure medications are often required due to frequent seizures at initia...

Full description

Bibliographic Details
Main Authors: Jiwon Lee, Young Ok Kim, Byung Chan Lim, Jeehun Lee
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Epilepsia Open
Subjects:
Online Access:https://doi.org/10.1002/epi4.12708
_version_ 1827935693903495168
author Jiwon Lee
Young Ok Kim
Byung Chan Lim
Jeehun Lee
author_facet Jiwon Lee
Young Ok Kim
Byung Chan Lim
Jeehun Lee
author_sort Jiwon Lee
collection DOAJ
description Abstract Objective Self‐limited infantile epilepsy (SeLIE) has distinctive clinical features, and the PRRT2 gene is known to be a considerable genetic cause. There have been a few studies on PRRT2‐positive SeLIE only, and anti‐seizure medications are often required due to frequent seizures at initial seizure onset. This study aimed to provide clinical information for the early recognition of patients with PRRT2‐positive SeLIE and to propose effective anti‐seizure medications for seizure control. Methods We retrospectively reviewed 36 patients diagnosed with SeLIE with genetically confirmed pathogenic variants of PRRT2. In addition, six atypical cases with neonatal‐onset seizures and unremitting after 3 years of age were included to understand the expanded clinical spectrum of PRRT2‐related epilepsy. We analyzed the initial presentation, clinical course, and seizure control response to anti‐seizure medications. Results Patients with PRRT2‐related epilepsy had characteristic seizure semiology at the initial presentation, including all afebrile, clustered (n = 23, 63.9%), short‐duration (n = 33, 91.7%), and bilateral tonic–clonic seizures (n = 26, 72.2%). Genetic analysis revealed that c. 649dupC was the most common variant, and six patients had a 16p11.2 microdeletion containing the PRRT2 gene. One‐third of the patients were sporadic cases without a family history of epilepsy or paroxysmal movement disorders. In the 33 patients treated with anti‐seizure medications, sodium channel blockers, such as carbamazepine, were the most effective in seizure control. Significance Our results delineated the clinical characteristics of PRRT2‐positive SeLIE, differentiating it from other genetic infantile epilepsies and discovered the effective anti‐seizure medications for initial clustered seizure control. If afebrile bilateral tonic–clonic seizures develop in a normally developed infant as a clustered pattern, PRRT2‐positive SeLIE should be considered as a possible diagnosis, and sodium channel blockers should be administered as the first medication for seizure control.
first_indexed 2024-03-13T07:58:29Z
format Article
id doaj.art-cf501b6fc67549cc926ca3a4435a859b
institution Directory Open Access Journal
issn 2470-9239
language English
last_indexed 2024-03-13T07:58:29Z
publishDate 2023-06-01
publisher Wiley
record_format Article
series Epilepsia Open
spelling doaj.art-cf501b6fc67549cc926ca3a4435a859b2023-06-02T03:50:17ZengWileyEpilepsia Open2470-92392023-06-018243644310.1002/epi4.12708PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockersJiwon Lee0Young Ok Kim1Byung Chan Lim2Jeehun Lee3Department of Pediatrics, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul South KoreaDepartment of Pediatrics Chonnam National University Medical School Gwangju South KoreaDepartment of Pediatrics, Seoul National University Children's Hospital Seoul National University College of Medicine Seoul South KoreaDepartment of Pediatrics, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul South KoreaAbstract Objective Self‐limited infantile epilepsy (SeLIE) has distinctive clinical features, and the PRRT2 gene is known to be a considerable genetic cause. There have been a few studies on PRRT2‐positive SeLIE only, and anti‐seizure medications are often required due to frequent seizures at initial seizure onset. This study aimed to provide clinical information for the early recognition of patients with PRRT2‐positive SeLIE and to propose effective anti‐seizure medications for seizure control. Methods We retrospectively reviewed 36 patients diagnosed with SeLIE with genetically confirmed pathogenic variants of PRRT2. In addition, six atypical cases with neonatal‐onset seizures and unremitting after 3 years of age were included to understand the expanded clinical spectrum of PRRT2‐related epilepsy. We analyzed the initial presentation, clinical course, and seizure control response to anti‐seizure medications. Results Patients with PRRT2‐related epilepsy had characteristic seizure semiology at the initial presentation, including all afebrile, clustered (n = 23, 63.9%), short‐duration (n = 33, 91.7%), and bilateral tonic–clonic seizures (n = 26, 72.2%). Genetic analysis revealed that c. 649dupC was the most common variant, and six patients had a 16p11.2 microdeletion containing the PRRT2 gene. One‐third of the patients were sporadic cases without a family history of epilepsy or paroxysmal movement disorders. In the 33 patients treated with anti‐seizure medications, sodium channel blockers, such as carbamazepine, were the most effective in seizure control. Significance Our results delineated the clinical characteristics of PRRT2‐positive SeLIE, differentiating it from other genetic infantile epilepsies and discovered the effective anti‐seizure medications for initial clustered seizure control. If afebrile bilateral tonic–clonic seizures develop in a normally developed infant as a clustered pattern, PRRT2‐positive SeLIE should be considered as a possible diagnosis, and sodium channel blockers should be administered as the first medication for seizure control.https://doi.org/10.1002/epi4.12708benign partial epilepsy in infancygenetic infantile epilepsyPRRT2 geneself‐limited infantile epilepsysodium channel blocker
spellingShingle Jiwon Lee
Young Ok Kim
Byung Chan Lim
Jeehun Lee
PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers
Epilepsia Open
benign partial epilepsy in infancy
genetic infantile epilepsy
PRRT2 gene
self‐limited infantile epilepsy
sodium channel blocker
title PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers
title_full PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers
title_fullStr PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers
title_full_unstemmed PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers
title_short PRRT2‐positive self‐limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers
title_sort prrt2 positive self limited infantile epilepsy initial seizure characteristics and response to sodium channel blockers
topic benign partial epilepsy in infancy
genetic infantile epilepsy
PRRT2 gene
self‐limited infantile epilepsy
sodium channel blocker
url https://doi.org/10.1002/epi4.12708
work_keys_str_mv AT jiwonlee prrt2positiveselflimitedinfantileepilepsyinitialseizurecharacteristicsandresponsetosodiumchannelblockers
AT youngokkim prrt2positiveselflimitedinfantileepilepsyinitialseizurecharacteristicsandresponsetosodiumchannelblockers
AT byungchanlim prrt2positiveselflimitedinfantileepilepsyinitialseizurecharacteristicsandresponsetosodiumchannelblockers
AT jeehunlee prrt2positiveselflimitedinfantileepilepsyinitialseizurecharacteristicsandresponsetosodiumchannelblockers